Stage specific requirement of platelet-derived growth factor receptor-α in embryonic development

Chen Qian1, Carol Wing Yan Wong1, Zhongluan Wu1

  • 1Department of Surgery, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China.

Plos One
|September 22, 2017
PubMed

Insights

Altering Platelet-Derived Growth Factor Receptor Alpha (PDGFRα) expression during mouse embryonic development causes skeletal and abdominal wall defects. The timing of PDGFRα deletion impacts the severity and type of congenital anomalies observed.

Area of Science:

  • Developmental Biology
  • Genetics
  • Molecular Biology

Background:

  • Platelet-derived growth factor receptor alpha (PDGFRα) is essential for embryonic development.
  • PDGFRα signaling is critical for the proper formation of multiple embryonic structures.
  • Previous studies indicated PDGFRα deletion leads to complex developmental defects, but temporal requirements were unclear.

Purpose of the Study:

  • To investigate the temporal requirements of PDGFRα during embryonic development.
  • To determine if the timing of PDGFRα deletion influences specific developmental anomalies.

Main Methods:

  • Conditional deletion of Pdgfra in Pdgfra-expressing tissues at various embryonic stages (E7.5-E10.5) in mice.
  • Examination and quantification of resulting developmental anomalies in embryos.
  • Analysis of apoptosis in Pdgfra-expressing tissues following deletion.

Main Results:

  • Conditional Pdgfra deletion at different embryonic stages resulted in orofacial cleft, spina bifida, rib cage deformities, and omphalocele.
  • The specific day of Pdgfra deletion influenced the incidence, severity, and combination of these anomalies.
  • Pdgfra deletion led to apoptosis of relevant tissues and subsequent developmental defects in their derivatives.

Conclusions:

  • Conditional Pdgfra knockout embryos exhibit phenotypes resembling common human congenital anomalies like orofacial cleft, spina bifida, and omphalocele.
  • Dysregulated PDGFRA expression is a potential cause of these congenital anomalies in humans.
  • Further research should focus on identifying regulatory elements of human PDGFRA and investigating their role in congenital defects.
Abstract